Purpose Lipid-lowering medications are often prescribed to decrease the risk of micro-and
macro-cardiovascular complications related to dyslipidaemia. Despite widespread …

The rising prevalence of type 2 diabetes poses a serious threat to human health and the
viability of many health care systems around the world. Although several prescription …

Abstract Purpose of Review Cardiovascular disease (CVD) continues to be the leading
cause of death for men and women in the USA. Statins have contributed significantly to …

Despite the widespread prescription of highly effective lipid-lowering medications, such as
the HMG-CoA reductase inhibitors (statins), a large portion of the population has lipid levels …

Objective: To evaluate the impact of changes in elective Abdominal Aortic Aneurysm (AAA)
management on life-expectancy of AAA patients. Background: Over the past decades AAA …

Background—Previous research shows that low socioeconomic position (SEP; especially
low income) is associated with statin nonadherence. We investigated the relationship …

Aims Poor adherence to medication therapy among type 2 diabetes patients is a clinical
challenge. We aimed to determine which factors are associated with the three phases of …

Bachground: Lipid-lowering drugs are effective preventive medication for patients at risk of
cardiovascular complications. However, medication adherence is suboptimal, thereby …

Aim Primary nonadherence (PNA) is defined as not filling the first prescription for a drug
treatment. PNA can lead not only to poor patient outcomes but also to exposure …

Medication adherence correlates with morbidity and mortality in patients with chronic heart
failure (CHF), but is difficult to assess. We conducted a retrospective methodological cohort …